Cargando…

Accurate digital quantification of tau pathology in progressive supranuclear palsy

The development of novel treatments for Progressive Supranuclear Palsy (PSP) is hindered by a knowledge gap of the impact of neurodegenerative neuropathology on brain structure and function. The current standard practice for measuring postmortem tau histology is semi-quantitative assessment, which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pansuwan, Tanrada, Quaegebeur, Annelies, Kaalund, Sanne S., Hidari, Eric, Briggs, Mayen, Rowe, James B., Rittman, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634011/
https://www.ncbi.nlm.nih.gov/pubmed/37946288
http://dx.doi.org/10.1186/s40478-023-01674-y
_version_ 1785132737831632896
author Pansuwan, Tanrada
Quaegebeur, Annelies
Kaalund, Sanne S.
Hidari, Eric
Briggs, Mayen
Rowe, James B.
Rittman, Timothy
author_facet Pansuwan, Tanrada
Quaegebeur, Annelies
Kaalund, Sanne S.
Hidari, Eric
Briggs, Mayen
Rowe, James B.
Rittman, Timothy
author_sort Pansuwan, Tanrada
collection PubMed
description The development of novel treatments for Progressive Supranuclear Palsy (PSP) is hindered by a knowledge gap of the impact of neurodegenerative neuropathology on brain structure and function. The current standard practice for measuring postmortem tau histology is semi-quantitative assessment, which is prone to inter-rater variability, time-consuming and difficult to scale. We developed and optimized a tau aggregate type-specific quantification pipeline for cortical and subcortical regions, in human brain donors with PSP. We quantified 4 tau objects (‘neurofibrillary tangles’, ‘coiled bodies’, ‘tufted astrocytes’, and ‘tau fragments’) using a probabilistic random forest machine learning classifier. The tau pipeline achieved high classification performance (F1-score > 0.90), comparable to neuropathologist inter-rater reliability in the held-out test set. Using 240 AT8 slides from 32 postmortem brains, the tau burden was correlated against the PSP pathology staging scheme using Spearman’s rank correlation. We assessed whether clinical severity (PSP rating scale, PSPRS) score reflects neuropathological severity inferred from PSP stage and tau burden using Bayesian linear mixed regression. Tufted astrocyte density in cortical regions and coiled body density in subcortical regions showed the highest correlation to PSP stage (r = 0.62 and r = 0.38, respectively). Using traditional manual staging, only PSP patients in stage 6, not earlier stages, had significantly higher clinical severity than stage 2. Cortical tau density and neurofibrillary tangle density in subcortical regions correlated with clinical severity. Overall, our data indicate the potential for highly accurate digital tau aggregate type-specific quantification for neurodegenerative tauopathies; and the importance of studying tau aggregate type-specific burden in different brain regions as opposed to overall tau, to gain insights into the pathogenesis and progression of tauopathies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01674-y.
format Online
Article
Text
id pubmed-10634011
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106340112023-11-10 Accurate digital quantification of tau pathology in progressive supranuclear palsy Pansuwan, Tanrada Quaegebeur, Annelies Kaalund, Sanne S. Hidari, Eric Briggs, Mayen Rowe, James B. Rittman, Timothy Acta Neuropathol Commun Research The development of novel treatments for Progressive Supranuclear Palsy (PSP) is hindered by a knowledge gap of the impact of neurodegenerative neuropathology on brain structure and function. The current standard practice for measuring postmortem tau histology is semi-quantitative assessment, which is prone to inter-rater variability, time-consuming and difficult to scale. We developed and optimized a tau aggregate type-specific quantification pipeline for cortical and subcortical regions, in human brain donors with PSP. We quantified 4 tau objects (‘neurofibrillary tangles’, ‘coiled bodies’, ‘tufted astrocytes’, and ‘tau fragments’) using a probabilistic random forest machine learning classifier. The tau pipeline achieved high classification performance (F1-score > 0.90), comparable to neuropathologist inter-rater reliability in the held-out test set. Using 240 AT8 slides from 32 postmortem brains, the tau burden was correlated against the PSP pathology staging scheme using Spearman’s rank correlation. We assessed whether clinical severity (PSP rating scale, PSPRS) score reflects neuropathological severity inferred from PSP stage and tau burden using Bayesian linear mixed regression. Tufted astrocyte density in cortical regions and coiled body density in subcortical regions showed the highest correlation to PSP stage (r = 0.62 and r = 0.38, respectively). Using traditional manual staging, only PSP patients in stage 6, not earlier stages, had significantly higher clinical severity than stage 2. Cortical tau density and neurofibrillary tangle density in subcortical regions correlated with clinical severity. Overall, our data indicate the potential for highly accurate digital tau aggregate type-specific quantification for neurodegenerative tauopathies; and the importance of studying tau aggregate type-specific burden in different brain regions as opposed to overall tau, to gain insights into the pathogenesis and progression of tauopathies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01674-y. BioMed Central 2023-11-09 /pmc/articles/PMC10634011/ /pubmed/37946288 http://dx.doi.org/10.1186/s40478-023-01674-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pansuwan, Tanrada
Quaegebeur, Annelies
Kaalund, Sanne S.
Hidari, Eric
Briggs, Mayen
Rowe, James B.
Rittman, Timothy
Accurate digital quantification of tau pathology in progressive supranuclear palsy
title Accurate digital quantification of tau pathology in progressive supranuclear palsy
title_full Accurate digital quantification of tau pathology in progressive supranuclear palsy
title_fullStr Accurate digital quantification of tau pathology in progressive supranuclear palsy
title_full_unstemmed Accurate digital quantification of tau pathology in progressive supranuclear palsy
title_short Accurate digital quantification of tau pathology in progressive supranuclear palsy
title_sort accurate digital quantification of tau pathology in progressive supranuclear palsy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634011/
https://www.ncbi.nlm.nih.gov/pubmed/37946288
http://dx.doi.org/10.1186/s40478-023-01674-y
work_keys_str_mv AT pansuwantanrada accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy
AT quaegebeurannelies accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy
AT kaalundsannes accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy
AT hidarieric accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy
AT briggsmayen accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy
AT rowejamesb accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy
AT rittmantimothy accuratedigitalquantificationoftaupathologyinprogressivesupranuclearpalsy